Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-06-05

Clinical Trial Update: LEADERS FREE IV (RCT): BioFreedom™ Ultra vs BioFreedom™ in HBR Patients [NA]

View source ↗

Summary

Clinical trial update for LEADERS FREE IV comparing BioFreedom Ultra to BioFreedom in high-bleeding-risk coronary artery disease patients; recruitment is ongoin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BioFreedom
  • BioFreedom Ultra

Snippet

Sponsor: Biosensors Europe SA | Conditions: Coronary Artery Disease, Chronic Stable Angina | NA | Status: RECRUITING